2015 -now Senior Scientific Advisor @ Antiva Biosciences Inc.
2013 -now Founder and CEO @ Revolution Pharma Consulting Inc.
2017 -2018 Scientific Advisor @
1993 -2013 Senior VP, Research and SIte Head @
1995 -2005 Adjunct Professor @ Department of Biochemistry, McGill University
1991 -1993 Group Leader @ Bristol-Myers Squib Pharmaceutical Research Institute
1988 -1991 Research Fellow @
1983 -1988 Visiting Associate, Lab of Hormone Action and Oncogenesis, Lab of Tumor Virus Genetics @ National Cancer Institute, National Institutes of Health
Michael Cordingley, based in Canada, is currently a Chief Scientific Officer at Transposon Therapeutics, Inc.. Michael Cordingley brings experience from previous roles at Antiva Biosciences Inc., Revolution Pharma Consulting Inc., Artemis Therapeutics, Inc. and Boehringer Ingelheim. Michael Cordingley holds a 1979 - 1983 Ph.D. in Virology @ University of Glasgow. With a robust skill set that includes Clinical Trials, Medical Writing, Planning, Translational Medicine, CRO and more. Michael Cordingley has 1 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.